Figure 1 | Scientific Reports

Figure 1

From: Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia

Figure 1

Normalized fold expression of plasma mir-146a. (A) Relative quantification of plasma mir-146a in patients with ALL (n = 84), B-ALL (n = 48), T-ALL (n = 39), and healthy controls (n = 25). The y-axis denotes relative expression of plasma mir-146a normalized to mir-16 as a reference gene. (B) The levels of plasma mir-146a significantly reduced after treatment in patients of ALL (P < 0.0001). (C) Receiver operating curve (ROC) analyses for ALL with an AUC of 1.00 representing 100% sensitivity and 100% specificity.

Back to article page